Synopsis of recent research by authors named "Tiana Dodd"
- Tiana Dodd's recent research primarily focuses on the safety profiles of medical treatments, specifically glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in type 2 diabetes patients, highlighting concerns about cancer risks and potential protective effects against certain malignancies like colorectal cancer.
- Another area of her work addresses the clinical implications of biliary cysts, emphasizing their association with cholestasis and increased biliary cancer risk, underscoring the need for aggressive cancer risk management in affected patients.
- Additionally, Dodd has explored the transport and toxicity of engineered nanomaterials, particularly concerning nose-to-brain mechanisms and their potential neurotoxic effects, as well as studying the histopathological impact of carbon nanotubes in a murine model, contributing to safety assessments of nanotechnology applications.
